StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 74.7%, against 70.3% the year before. The highest annual figure on record is 74.7% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202574.7%+4.4
FY2024Dec 31, 202470.3%+2.7
FY2023Dec 31, 202367.6%+0.1
FY2022Dec 31, 202267.5%−4.2
FY2021Dec 31, 202171.7%−1.3
FY2020Dec 31, 202073.0%+1.4
FY2019Dec 31, 201971.6%+7.0
FY2018Dec 31, 201864.7%–

More Burning Rock Biotech figures

See a number that looks wrong?